---
figid: PMC4062952__ijbsv10p0596g001
figtitle: Four androgen metabolism pathways to DHT synthesis
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
pmcid: PMC4062952
filename: ijbsv10p0596g001.jpg
figlink: /pmc/articles/PMC4062952/figure/F1/
number: F1
caption: Four androgen metabolism pathways to DHT synthesis. Pathway 1 is the 5α-reduction
  of T to DHT (dashed lines). Pathway 2 uses adrenal androgens, DHEA or ASD, to synthesize
  T or 5α-dione that are converted to DHT (faint gray long dashes). Pathway 3 is the
  cholesterol pathway (small gray dashes). Pathway 4 is the backdoor pathway of DHT
  synthesis using androstanediol instead of T to generate DHT (outlined in bold).
  Abiraterone inhibits 17α-hydroxylase and 17,20-lyase of CYP17A1 (relevant to Pathways
  2 and 4) whereas TAK-700 or TOK-001 inhibit only 17,20-lyase (relevant to Pathway
  2).
papertitle: Roles for the Backdoor Pathway of Androgen Metabolism in Prostate Cancer
  Response to Castration and Drug Treatment.
reftext: Michael V. Fiandalo, et al. Int J Biol Sci. 2014;10(6):596-601.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7805432
figid_alias: PMC4062952__F1
figtype: Figure
redirect_from: /figures/PMC4062952__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4062952__ijbsv10p0596g001.html
  '@type': Dataset
  description: Four androgen metabolism pathways to DHT synthesis. Pathway 1 is the
    5α-reduction of T to DHT (dashed lines). Pathway 2 uses adrenal androgens, DHEA
    or ASD, to synthesize T or 5α-dione that are converted to DHT (faint gray long
    dashes). Pathway 3 is the cholesterol pathway (small gray dashes). Pathway 4 is
    the backdoor pathway of DHT synthesis using androstanediol instead of T to generate
    DHT (outlined in bold). Abiraterone inhibits 17α-hydroxylase and 17,20-lyase of
    CYP17A1 (relevant to Pathways 2 and 4) whereas TAK-700 or TOK-001 inhibit only
    17,20-lyase (relevant to Pathway 2).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DHRS9
  - AKR1C2
  - CYP17A1
  - ARSD
  - AKR1C3
  - CYP11A1
  - HSD3B1
  - abiraterone
  - Androstenedione
  - Androsterone
  - Cholesterol
  - DHEA
  - Dehydroepiandrosterone
  - 17a-OH dihydroprogesterone
  - Dihydroprogesterone
  - 17a-OH-Allopregnanolone
  - Allopregnanolone
  - 17a-OH-Pregnenolone
  - Pregnenolone
  - 17a-OH-Progesterone
  - Progesterone
  - Dihydrotestosterone
  - Testosterone
  - Androstenediol
  - finasteride
---
